Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ahn

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Journal of the American Chemical Society|December 15, 2015
A Panel of Protease-Responsive RNA Polymerases Respond to Biochemical Signals by Production of Defined RNA Outputs in Live CellsJinyue Pu, Ian Chronis, Daniel Ahn, et al.
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|August 21, 2013
Dacryocystorhinostomy: History, evolution and future directionsVladimir S Yakopson, Joseph C Flanagan, Daniel Ahn, et al.
Future Oncology (London, England)|September 13, 2022
Real-world outcomes in patients with first-line and second-line therapy for advanced esophageal squamous cell carcinomaDaniel Ahn, Michelle Sidel, Laura Panattoni, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2018
Pathway-Specific Asymmetries between ON and OFF Visual SignalsSneha Ravi, Daniel Ahn, Martin Greschner, et al.
Expert Opinion on Therapeutic Targets|March 11, 2017
Signaling pathways as therapeutic targets in biliary tract cancerJennifer Yang, Matthew R Farren, Daniel Ahn, et al.
Radiology|June 29, 2004
Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration indexStanley Lu, Daniel Ahn, Glyn Johnson, et al.
Chinese Clinical Oncology|December 22, 2025
Response to DNA-damaging agents and PARP inhibitors in ATM mutated metastatic colorectal cancer: case seriesCody Eslinger, Daniel Walden, Mohamad Bassam Sonbol, et al.
Chronic Illness|April 28, 2023
Assessing knowledge of end-stage kidney disease and treatment options in hospitalized African American patients undergoing hemodialysisAkilah King, Jacob Tanumihardjo, Daniel Ahn, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2020
Perspectives on immunotherapy utilization for hepatobiliary cancers in the United StatesPedro Luiz Serrano Usón Junior, Daniel Ahn, Mohamad Bassam Sonbol, et al.
The Oncologist|June 9, 2020
Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsMojun Zhu, Mohamad Bassam Sonbol, Thorvardur Halfdanarson, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of the American Chemical Society|December 15, 2015
A Panel of Protease-Responsive RNA Polymerases Respond to Biochemical Signals by Production of Defined RNA Outputs in Live CellsJinyue Pu, Ian Chronis, Daniel Ahn, et al.
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|August 21, 2013
Dacryocystorhinostomy: History, evolution and future directionsVladimir S Yakopson, Joseph C Flanagan, Daniel Ahn, et al.
Future Oncology (London, England)|September 13, 2022
Real-world outcomes in patients with first-line and second-line therapy for advanced esophageal squamous cell carcinomaDaniel Ahn, Michelle Sidel, Laura Panattoni, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2018
Pathway-Specific Asymmetries between ON and OFF Visual SignalsSneha Ravi, Daniel Ahn, Martin Greschner, et al.
Expert Opinion on Therapeutic Targets|March 11, 2017
Signaling pathways as therapeutic targets in biliary tract cancerJennifer Yang, Matthew R Farren, Daniel Ahn, et al.
Radiology|June 29, 2004
Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration indexStanley Lu, Daniel Ahn, Glyn Johnson, et al.
Chinese Clinical Oncology|December 22, 2025
Response to DNA-damaging agents and PARP inhibitors in ATM mutated metastatic colorectal cancer: case seriesCody Eslinger, Daniel Walden, Mohamad Bassam Sonbol, et al.
Chronic Illness|April 28, 2023
Assessing knowledge of end-stage kidney disease and treatment options in hospitalized African American patients undergoing hemodialysisAkilah King, Jacob Tanumihardjo, Daniel Ahn, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2020
Perspectives on immunotherapy utilization for hepatobiliary cancers in the United StatesPedro Luiz Serrano Usón Junior, Daniel Ahn, Mohamad Bassam Sonbol, et al.
The Oncologist|June 9, 2020
Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsMojun Zhu, Mohamad Bassam Sonbol, Thorvardur Halfdanarson, et al.
Pageof 6